Clinical Trial Update: Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating immunotherapy with or without stereotactic body radiation therapy in adults with advanced hepatocellular carcinoma, including stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immunotherapy (immunotherapy)

Snippet

Sponsor: NRG Oncology | Conditions: Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | Phase 3 | Status: RECRUITING